FDA finds cancer-causing chemical in heartburn medicine Zantac
Here's what you need to know about probable Carcinogen found in Zantac
Health regulators worldwide, including the US Food and Drug Administration (FDA) have learned that there is a possibility that stomach drug Ranitidine taken by millions of people could be tainted with a cancer-causing agent. According to FDA, the source of this contamination is currently being investigated.
Ranitidine belongs to a class of medicines known as H2 (histsamine-2) blockers, which work by blocking histamine receptors in the stomach and reducing the production of stomach acid. It is used to treat and prevent conditions caused by excess acid in the stomach such as heartburn and stomach ulcers.
Ranitidine belongs to a class of medicines known as H2 (histsamine-2) blockers, which work by blocking histamine receptors in the stomach and reducing the production of stomach acid. It is used to treat and prevent conditions caused by excess acid in the stomach such as heartburn and stomach ulcers.
Load Next Story